A carregar...

Immunotherapy for Merkel cell carcinoma: a turning point in patient care

Merkel Cell carcinoma (MCC) is a rare but aggressive cancer, with an estimated disease-associated mortality as high as 46%. MCC has proven to be an immunologically responsive disease and the advent of immune checkpoint inhibitors has changed the treatment landscape for patients with advanced MCC. In...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Chan, Isaac S., Bhatia, Shailender, Kaufman, Howard L., Lipson, Evan J.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865292/
https://ncbi.nlm.nih.gov/pubmed/29566749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-018-0335-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!